TECH BUYER May 2019 - IDC TechScape - Doc # US45061619

IDC TechScape: Worldwide Life Science Commercial IoT Technologies, 2019

By: Michael TownsendResearch Manager, Life Sciences Commercial Strategies


This IDC study provides a systematic assessment of IoT technology use cases and adoption momentum within life science commercial operations. This IDC TechScape is an evaluation model based on a comprehensive framework and a set of parameters that assess a technology's adoption progress relative to one another and to those factors expected to be most conducive to success over both the short term and the long term. In breaking technologies into three major adoption categories — transformational, incremental, and opportunistic — this IDC TechScape aspires to provide IT buyers with an industry snapshot as to where specific technologies lie today relative to current industry best practices. In addition, this IDC TechScape identifies technologies likely to become best practices in the future and their current state of adoption maturity relative to each other. Within our discussion of individual technologies, we also identify our analyst best opinions regarding key momentum factors — highlighted as IDC TechScape Markers of Momentum, where we rate technologies based on adoption speed, risk, and market interest.

According to Michael Townsend, research director, Life Sciences Commercial Strategies at IDC, "The commercial segment of the life science industry continues to invest heavily in IoT technology for a variety of applications in production, supply chain, facilities, and sales operations. These IoT use cases and technology are an important sector of the life science industry's drive toward digital transformation and automation affecting the entire enterprise, the supply chain, and customers. IDC expects continued heavy investment and innovation in IoT and associated technology going forward."



Get More

When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.

Related Links

Do you have questions about this document
or available subscriptions?

Contact Us